We are live on
!
Find out more
National Bank of Canada Portfolio holdings
AUM
$140B
1-Year Est. Return
46.34%
This Fund
S&P 500
This Quarter
Est. Return
+12.88%
1 Year Est. Return
+46.34%
3 Year Est. Return
+120.97%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$62.6B
AUM Growth
-$3.11B
(-4.7%)
Cap. Flow
-$8.57B
Cap. Flow
% of AUM
-13.7%
Top 10 Holdings %
Top 10 Hldgs %
23.97%
Holding
2,962
New
190
Increased
862
Reduced
990
Closed
256
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$739M |
| 2 |
Apple
AAPL
|
+$436M |
| 3 |
Broadcom
AVGO
|
+$405M |
| 4 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$305M |
| 5 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$202M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.04B |
| 2 |
NVIDIA
NVDA
|
+$709M |
| 3 |
Advanced Micro Devices
AMD
|
+$687M |
| 4 |
Toronto Dominion Bank
TD
|
+$647M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$483M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.1% |
| 2 | Financials | 18.09% |
| 3 | Healthcare | 6.87% |
| 4 | Consumer Discretionary | 6.64% |
| 5 | Industrials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AXON
751
Axon Enterprise
AXON
$50B
| $5.24M | 0.01% |
20,837
-3,746
| -15% | -$844K |
|
752
FirstEnergy
FE
$27.1B
| $5.24M | 0.01% |
139,976
+10,976
| +9% | +$397K |
|
753
StepStone Group
STEP
$4.28B
| $5.2M | 0.01% |
164,516
+70,454
| +75% | +$1.99M |
|
754
Ameren
AEE
$30.2B
| $5.18M | 0.01% |
70,049
-18,128
| -21% | -$1.38M |
|
755
Omega Healthcare
OHI
$13.9B
| $5.18M | 0.01% |
167,930
+61,955
| +58% | +$1.99M |
|
756
Casella Waste Systems
CWST
$5.79B
| $5.17M | 0.01% |
63,542
-4,920
| -7% | -$395K |
|
757
Tenet Healthcare
THC
$21.5B
| $5.15M | 0.01% |
67,695
+49,255
| +267% | +$3.12M |
|
|
FISV
758
Fiserv Inc
FISV
$29.5B
| $5.14M | 0.01% |
38,696
-414
| -1% | -$50.8K |
|
759
Conagra Brands
CAG
$7.39B
| $5.14M | 0.01% |
174,022
+24,094
| +16% | +$675K |
|
760
Las Vegas Sands
LVS
$29.6B
| $5.12M | 0.01% |
99,773
-105,683
| -51% | -$5M |
|
761
Southwest Airlines
LUV
$22B
| $5.11M | 0.01% |
179,576
+32,861
| +22% | +$855K |
|
|
AYX
762
DELISTED
Alteryx Inc
AYX
| $5.1M | 0.01% |
108,426
-79,629
| -42% | -$3.09M |
|
763
McCormick & Company Non-Voting
MKC
$14.6B
| $5.07M | 0.01% |
72,905
+6,892
| +10% | +$451K |
|
764
International Paper
IP
$21.8B
| $5.07M | 0.01% |
138,663
-324,032
| -70% | -$11.3M |
|
765
Bio-Rad Laboratories Class A
BIO
$9.66B
| $5.04M | 0.01% |
15,734
-2,397
| -13% | -$751K |
|
766
Ciena
CIEN
$62.7B
| $5.03M | 0.01% |
111,507
+87,412
| +363% | +$3.85M |
|
767
Equity Residential
EQR
$24.7B
| $5.02M | 0.01% |
80,734
-474,355
| -85% | -$27.4M |
|
768
PUT
Dutch Bros
BROS
$8.93B
| $5M | 0.01% |
1,610
-2,679
| -62% | -$73K |
|
769
Nordson
NDSN
$17.3B
| $4.99M | 0.01% |
19,308
+4,770
| +33% | +$1.11M |
|
770
Enphase Energy
ENPH
$5.39B
| $4.99M | 0.01% |
38,023
-56,821
| -60% | -$6.03M |
|
771
Viatris
VTRS
$18.4B
| $4.98M | 0.01% |
436,739
+17,681
| +4% | +$169K |
|
772
Calix
CALX
$2.51B
| $4.97M | 0.01% |
114,596
-29,694
| -21% | -$1.19M |
|
773
Builders FirstSource
BLDR
$7.91B
| $4.93M | 0.01% |
29,837
+28,341
| +1,894% | +$3.77M |
|
774
United Therapeutics
UTHR
$21.5B
| $4.89M | 0.01% |
21,531
-19,637
| -48% | -$4.53M |
|
775
Omnicom Group
OMC
$24.2B
| $4.89M | 0.01% |
56,034
-11,187
| -17% | -$882K |
|
Similar funds
National Bank of Canada's Q4 2023 Portfolio in Review
As of Q4 2023, National Bank of Canada held 2,962 positions worth $62.6B, down 4.7% from $65.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
National Bank of Canada withdrew a net $8.57B in Q4 2023, closing 256 positions and reducing 990 holdings. Its most notable exit was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $102M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
Against the trend, National Bank of Canada opened a new position in Mirati Therapeutics, Inc. Common Stock worth $28M.
- National Bank of Canada's largest Q4 2023 buy was Mirati Therapeutics, Inc. Common Stock: 473,500 shares worth $28M.
- National Bank of Canada added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $739M increase.
- National Bank of Canada's biggest Q4 2023 reduction was Amazon, cutting an estimated $1.04B.
- National Bank of Canada fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $102M.
- National Bank of Canada's ten largest holdings make up 24% of its $62.6B portfolio in Q4 2023.
- National Bank of Canada opened 190 new positions and closed 256 in Q4 2023.
- National Bank of Canada's portfolio value fell 4.7% quarter-over-quarter to $62.6B.
Based on National Bank of Canada's 13F filing for Q4 2023, filed 6 Feb 2024.